Association Between Two Common Polymorphisms (single Nucleotide Polymorphism -250G/A and -514C/T) of the Hepatic Lipase Gene and Coronary Artery Disease in Type 2 Diabetic Patients

Overview

Journal Adv Biomed Res

Specialty Biomedical Engineering

Date 2016 Mar 26

PMID 27014654

Citations 6

Authors

Ghorban Mohammadzadeh

Mohammad-Ali Ghaffari

Mohammad Bazyar

Alireza Kheirollah

Affiliations

Soon will be listed here.

Abstract

Background: Variations in the hepatic lipase (HL) gene are the potential candidate for coronary artery disease (CAD) especially in type 2 diabetes mellitus (T2DM) in diverse populations. We assessed the association of -514C/T and -250G/A polymorphisms in HL (LIPC) gene with CAD risk in Iranian population with type 2 diabetes.

Materials And Methods: We evaluated 322 type 2 diabetic patients, 166 patients with normal angiograms as controls and 156 patients those identified with CAD undergoing their first coronary angiography as CAD cases. Genotyping of -514C/T and -250G/A polymorphisms in the promoter of the LIPC gene were studied by polymerase chain reaction (PCR)-restriction fragment length polymorphism technique.

Results: Genotype distributions in CAD cases (73.7%, 20.5%, and 5.8% for -250G/A) and (62.2%, 32.7%, and 5.1% for -514C/T) were significantly different from those in controls (60.8%, 37.4%, and 1.8% for -250G/A) and (51.2%, 48.2%, and 0.6% for -514C/T). CAD cases had lower A-allele frequency than controls (0.131 vs. 0.196, P = 0.028). The odds ratio for the presence of -250 (GG + GA) genotype and A allele in CAD cases were 2.206 (95% confidence interval [CI] =1.33-3.65, P = 0.002) and 1.609 (95% CI = 1.051 -2.463, P = 0.029) respectively. Haplotype analysis demonstrated a significant association between especially LIPC double mutant (-250 A/-514 T) haplotype and presence of CAD.

Conclusion: Our findings indicated that -250 G/A polymorphism rather than -514 C/T polymorphism of LIPC gene is more associated with the increased risk of CAD particularly in women with T2DM.

Citing Articles

Association of the ESR1 (rs9340799), OLR1 (rs3736234), LIPC (rs2070895), VDR (rs2228570), and CETP (rs708272) Polymorphisms With Risk of Coronary Artery Disease in Iranian Patients.

Miri Karam Z, Yari A, Najmadini A, Khorasani N, Attari R, Jafarinejad-Farsangi S J Clin Lab Anal. 2024; 38(6):e25026.

PMID: 38506378 PMC: 10997818. DOI: 10.1002/jcla.25026.

Association of C677T (rs1081133) and A1298C (rs1801131) Methylenetetrahydrofolate Reductase Variants with Breast Cancer Susceptibility Among Asians: A Systematic Review and Meta-Analysis.

Rezaee M, Akbari H, Momeni-Moghaddam M, Moazzen F, Salahi S, Jahankhah R Biochem Genet. 2021; 59(2):367-397.

PMID: 33387129 DOI: 10.1007/s10528-020-10020-z.

Hepatic lipase (LIPC) sequencing in individuals with extremely high and low high-density lipoprotein cholesterol levels.

Pirim D, Bunker C, Hokanson J, Hamman R, Demirci F, Kamboh M PLoS One. 2020; 15(12):e0243919.

PMID: 33326441 PMC: 7743991. DOI: 10.1371/journal.pone.0243919.

Low-density lipoprotein receptor gene mutation at Exon 2 and 4 in premature coronary artery disease in our population.

Rehman S, Ahmad T, Hayat A, Tahir S Pak J Med Sci. 2019; 35(4):1143-1148.

PMID: 31372158 PMC: 6659052. DOI: 10.12669/pjms.35.4.1308.

Association of LIPC -250G/A and -514C/T polymorphisms and hypertension: a systematic review and meta-analysis.

Zhao X, Ren Y, Li H, Wu Y Lipids Health Dis. 2018; 17(1):238.

PMID: 30322388 PMC: 6190538. DOI: 10.1186/s12944-018-0884-4.

References

Dugi K, Brandauer K, Schmidt N, Nau B, Schneider J, Mentz S . Low hepatic lipase activity is a novel risk factor for coronary artery disease. Circulation. 2001; 104(25):3057-62. DOI: 10.1161/hc5001.100795. View

Deeb S, Zambon A, Carr M, Ayyobi A, Brunzell J . Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet. J Lipid Res. 2003; 44(7):1279-86. DOI: 10.1194/jlr.R200017-JLR200. View

Fan Y, Laaksonen R, Janatuinen T, Vesalainen R, Nuutila P, Koivula T . Hepatic lipase gene variation is related to coronary reactivity in healthy young men. Eur J Clin Invest. 2001; 31(7):574-80. DOI: 10.1046/j.1365-2362.2001.00858.x. View

De Andrade F, Silveira F, Arsand M, Antunes A, Torres M, Zago A . Association between -250G/A polymorphism of the hepatic lipase gene promoter and coronary artery disease and HDL-C levels in a Southern Brazilian population. Clin Genet. 2004; 65(5):390-5. DOI: 10.1111/j.0009-9163.2004.00243.x. View

Austin M, Breslow J, Hennekens C, Buring J, Willett W, Krauss R . Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988; 260(13):1917-21. View

Sharrett A, Ballantyne C, Coady S, Heiss G, Sorlie P, Catellier D . Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2001; 104(10):1108-13. DOI: 10.1161/hc3501.095214. View

Bertolini S, Pisciotta L, Di Scala L, Langheim S, Bellocchio A, Masturzo P . Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia. Atherosclerosis. 2004; 174(1):57-65. DOI: 10.1016/j.atherosclerosis.2003.12.037. View

Jansen H, Verhoeven A, Sijbrands E . Hepatic lipase: a pro- or anti-atherogenic protein?. J Lipid Res. 2002; 43(9):1352-62. DOI: 10.1194/jlr.r200008-jlr200. View

Botma G, Verhoeven A, Jansen H . Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by Upstream Stimulatory Factor. Atherosclerosis. 2001; 154(3):625-32. DOI: 10.1016/s0021-9150(00)00478-0. View

10.

Guerra R, Wang J, Grundy S, Cohen J . A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci U S A. 1997; 94(9):4532-7. PMC: 20757. DOI: 10.1073/pnas.94.9.4532. View

11.

Ko Y, Hsu L, Hsu K, Ko Y, Lee Y . The interactive effects of hepatic lipase gene promoter polymorphisms with sex and obesity on high-density-lipoprotein cholesterol levels in Taiwanese-Chinese. Atherosclerosis. 2004; 172(1):135-42. DOI: 10.1016/j.atherosclerosis.2003.09.013. View

12.

Miller S, Dykes D, Polesky H . A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16(3):1215. PMC: 334765. DOI: 10.1093/nar/16.3.1215. View

13.

Wilson P, DAgostino R, Levy D, Belanger A, Silbershatz H, Kannel W . Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97(18):1837-47. DOI: 10.1161/01.cir.97.18.1837. View

14.

Wei M, Lu Y, Li P . [Association of the hepatic lipase gene -250G/A promoter polymorphism with the susceptibility to type 2 diabetes mellitus combining with coronary heart disease]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009; 26(2):219-22. DOI: 10.3760/cma.j.issn.1003-9406.2009.02.023. View

15.

Shohet R, Vega G, Anwar A, Cigarroa J, Grundy S, Cohen J . Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations. Arterioscler Thromb Vasc Biol. 1999; 19(8):1975-8. DOI: 10.1161/01.atv.19.8.1975. View

16.

Zambon A, Deeb S, Hokanson J, Brown B, Brunzell J . Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. Arterioscler Thromb Vasc Biol. 1998; 18(11):1723-9. DOI: 10.1161/01.atv.18.11.1723. View

17.

Cai S, Wong D, Chen S, Chan L . Structure of the human hepatic triglyceride lipase gene. Biochemistry. 1989; 28(23):8966-71. DOI: 10.1021/bi00449a002. View

18.

Roberts C, Ng C, Hama S, Eliseo A, Barnard R . Effect of a short-term diet and exercise intervention on inflammatory/anti-inflammatory properties of HDL in overweight/obese men with cardiovascular risk factors. J Appl Physiol (1985). 2006; 101(6):1727-32. DOI: 10.1152/japplphysiol.00345.2006. View

19.

Zdravkovic S, Wienke A, Pedersen N, Marenberg M, Yashin A, de Faire U . Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins. J Intern Med. 2002; 252(3):247-54. DOI: 10.1046/j.1365-2796.2002.01029.x. View

20.

Andersen R, Wittrup H, Tybjaerg-Hansen A, Steffensen R, Schnohr P, Nordestgaard B . Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study. J Am Coll Cardiol. 2003; 41(11):1972-82. DOI: 10.1016/s0735-1097(03)00407-8. View